关于葡萄糖皮质醇诱导骨质疏松症的综合性审查:一种药物引起的疾病
Asim Rahman1, Md Faheem Haider1
1Faculty of Pharmacy, Integral University, Lucknow 226026, India.
葡萄糖皮质激素 (GCs) 是重要的药物,但可能导致骨质损失,导致GC诱导的骨质疏松症. 风险因素如剂量,持续时间和患者病史对于评估骨折风险至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质醇 (GCs) 广泛用于治疗自身免疫性疾病,炎症和癌症.
- GC的管理是二次骨质疏松症的主要原因,导致显著的骨质损失.
- GCs通过增加再吸收和抑制形成对骨产生有害影响.
研究的目的:
- 总结一下葡萄糖皮质激素对骨健康的影响.
- 突出了GC诱导的骨质疏松症背后的机制.
- 强调对GC诱导的骨质疏松症风险因素评估的重要性.
主要方法:
- 关于葡萄糖皮质醇对骨的影响的文献综述.
- 对GC诱导的骨损失机制的分析.
- 确定GC诱导骨质疏松症的主要危险因素.
主要成果:
- 草甘治疗与增加骨质再吸收和减少骨形成有关.
- 由GC引起的骨损失增加了脊椎和非脊椎骨折的风险.
- 骨折风险随着更高的GC剂量和更长的治疗持续时间 (≥3个月) 升级.
结论:
- 由GC诱导的骨质疏松症是一个重要的临床问题.
- 评估患者特定的风险因素 (剂量,持续时间,年龄,性别,先前的骨折) 对于管理GC治疗至关重要.
- 早期评估风险因素可以帮助缓解GC相关的骨并发症.
更多相关视频
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
相关概念视频
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology
